{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:00:53Z","timestamp":1787497253986,"version":"build-2736575974"},"reference-count":34,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"unspecified","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Merck KGaA, Darmstadt, Germany","award":["10.13039\/100009945"],"award-info":[{"award-number":["10.13039\/100009945"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2022,11,17]]},"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>We previously reported an increased risk of being small for gestational age (SGA) and a decreased risk of being large for gestational age (LGA) after in utero exposure to metformin compared with insulin exposure. This follow-up study investigated if these observations remain when metformin exposure (henceforth, metformin cohort) is compared with non-pharmacological antidiabetic treatment of gestational diabetes mellitus (GDM; na\u00efve cohort), instead of insulin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research design and methods\u202f<\/jats:title>\n                    <jats:p>This was a Finnish population register-based cohort study from singleton children born during 2004\u20132016. Birth outcomes from metformin cohort (n=3964) and the na\u00efve cohort (n=82\u2009675) were used in the main analyses. Additional analyses were conducted in a subcohort, restricting the metformin cohort to children of mothers with GDM only (n=2361). Results were reported as inverse probability of treatment weighted OR (wOR), with the na\u00efve cohort as reference.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results\u202f\u202f<\/jats:title>\n                    <jats:p>No difference was found for the outcome of SGA between the cohorts in the main analyses (wOR 0.97, 95% CI 0.73 to 1.27) or in the additional analyses (wOR 1.01, 95% CI 0.75 to 1.37). No difference between the cohorts was found for the risk of LGA (wOR 0.91, 95% CI 0.75 to 1.11) in the main analyses but a decreased risk was observed in the additional analyses (wOR 0.72, 95% CI 0.56 to 0.92).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions\u202f<\/jats:title>\n                    <jats:p>This follow-up study found no increase in the risk of SGA or LGA after in utero exposure to metformin, compared with drug-na\u00efve GDM. The decreased risk of LGA in mothers with GDM may suggest residual confounding. The lack of increased SGA risk aligns with findings from studies using metformin in non-diabetic pregnancies. In contrast, lower birth weight and increased SGA birth risk were observed in GDM pregnancies for metformin versus insulin. Metformin should be avoided with emerging growth restriction in utero. The interplay of intrauterine hyperglycemia and pharmacological treatments needs further assessment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjdrc-2022-003056","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T09:00:32Z","timestamp":1669971632000},"page":"e003056","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Metformin in pregnancy and risk of abnormal growth outcomes at birth: a register-based cohort study"],"prefix":"10.1136","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct02980276","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02980276","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8374-4026","authenticated-orcid":false,"given":"Kerstin MG","family":"Brand","sequence":"first","affiliation":[{"name":"Merck KGaA, Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Thoren","sequence":"additional","affiliation":[{"name":"Global Database Studies, IQVIA, Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaak","family":"S\u00f5najalg","sequence":"additional","affiliation":[{"name":"Global Database Studies, IQVIA, Tartu, Estonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Boutmy","sequence":"additional","affiliation":[{"name":"Merck KGaA, Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0254-5560","authenticated-orcid":false,"given":"Caroline","family":"Foch","sequence":"additional","affiliation":[{"name":"Merck KGaA, Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Schlachter","sequence":"additional","affiliation":[{"name":"Merck KGaA, Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja M","family":"Hakkarainen","sequence":"additional","affiliation":[{"name":"Global Database Studies, IQVIA, Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Saarelainen","sequence":"additional","affiliation":[{"name":"Global Database Studies, IQVIA, Espoo, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,12,2]]},"reference":[{"key":"2025073111394159000_10.6.e003056.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-000759"},{"key":"2025073111394159000_10.6.e003056.2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19010019"},{"key":"2025073111394159000_10.6.e003056.3","first-page":"e306","article-title":"Metformin therapy for the management of infertility in women with polycystic ovary syndrome: scientific impact paper No. 13","volume":"124","year":"2017","journal-title":"BJOG"},{"key":"2025073111394159000_10.6.e003056.4","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00592-014-0570-6","article-title":"The degree of fetal metformin exposure does not influence fetal outcome in gestational diabetes mellitus","volume":"51","author":"Tertti","year":"2014","journal-title":"Acta Diabetol"},{"key":"2025073111394159000_10.6.e003056.5","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13150"},{"key":"2025073111394159000_10.6.e003056.6","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2019.1670804"},{"key":"2025073111394159000_10.6.e003056.7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00404-014-3566-0","article-title":"Effect comparison of metformin with insulin treatment for gestational diabetes: a meta-analysis based on RCTs","volume":"292","author":"Li","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"2025073111394159000_10.6.e003056.8","unstructured":"Eu SMPC Glucophage\u00ae 2022."},{"key":"2025073111394159000_10.6.e003056.9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2021-002363"},{"key":"2025073111394159000_10.6.e003056.10","unstructured":"Nicolaou V , Norman JE . Metformin in pregnancy. in: metformin \u2013 60 years of clinical experience for a better tomorrow. WILEY-VCH Verlag GmbH & Co 2017:93\u2013107."},{"key":"2025073111394159000_10.6.e003056.11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/9804708","article-title":"Comparative efficacy and safety of metformin, glyburide, and insulin in treating gestational diabetes mellitus: a meta-analysis","volume":"2019","author":"Guo","year":"2019","journal-title":"J Diabetes Res"},{"key":"2025073111394159000_10.6.e003056.12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003126","article-title":"Comparative impact of pharmacological treatments for gestational diabetes on neonatal anthropometry independent of maternal glycaemic control: A systematic review and meta-analysis","volume":"17","author":"Tarry-Adkins","year":"2020","journal-title":"PLoS Med"},{"key":"2025073111394159000_10.6.e003056.13","unstructured":"Parturients, delivers and newborns - THL. Finnish Institute for Health and Welfare (THL), Finland. Available: https:\/\/thl.fi\/en\/web\/thlfi-en\/statistics-and-data\/data-and-services\/quality-and-statistical-principles\/quality-descriptions\/parturients-delivers-and-newborns [Accessed 28 Apr 2022]."},{"key":"2025073111394159000_10.6.e003056.14","unstructured":"Kela . (The Social Insurance Institution). Quality description - Statistics on dispensed medicines reimbursable under the NHI scheme. Available: https:\/\/www.kela.fi\/web\/en\/statistics-on-dispensed-medicines-reimbursable-under-the-nhi-scheme-quality-description [Accessed 28 Apr 2022]."},{"key":"2025073111394159000_10.6.e003056.15","unstructured":"Care Register for Health Care - THL . Finnish Institute for health and welfare (THL), Finland. Available: https:\/\/thl.fi\/en\/web\/thlfi-en\/statistics-and-data\/data-and-services\/register-descriptions\/care-register-for-health-care [Accessed 28 Apr 2022]."},{"key":"2025073111394159000_10.6.e003056.16","unstructured":"Register of Primary Health Care visits - THL. Finnish Institute for Health and Welfare (THL), Finland. Available: https:\/\/thl.fi\/en\/web\/thlfi-en\/statistics-and-data\/data-and-services\/register-descriptions\/register-of-primary-health-care-visits [Accessed 28 Apr 2022]."},{"key":"2025073111394159000_10.6.e003056.17","unstructured":"Statistical data - Statistics Finland. Available: https:\/\/stat.fi\/en\/statistical-data [Accessed 2 May 2022]."},{"key":"2025073111394159000_10.6.e003056.18","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S2213-8587(20)30310-7","article-title":"Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial","volume":"8","author":"Feig","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025073111394159000_10.6.e003056.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509819"},{"key":"2025073111394159000_10.6.e003056.20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-8587(18)30310-3","article-title":"Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the grow randomised, double-blind, placebo-controlled trial","volume":"7","author":"Dodd","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025073111394159000_10.6.e003056.21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12958-022-00905-6","article-title":"Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study","volume":"20","author":"Fornes","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"2025073111394159000_10.6.e003056.22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/ppe.12809","article-title":"Risk of large for gestational age births at early, full and late term in relation to pre-pregnancy body mass index: mediation by gestational diabetes status","volume":"36","author":"Kondracki","year":"2022","journal-title":"Paediatr Perinat Epidemiol"},{"key":"2025073111394159000_10.6.e003056.23","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ijgo.13718","article-title":"Metformin in gestational diabetes mellitus: a double\u2010blind placebo\u2010controlled randomized trial","volume":"156","author":"Tew","year":"2022","journal-title":"Intl J Gynecology & Obste"},{"key":"2025073111394159000_10.6.e003056.24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002848","article-title":"Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: a systematic review and meta-analysis","volume":"16","author":"Tarry-Adkins","year":"2019","journal-title":"PLoS Med"},{"key":"2025073111394159000_10.6.e003056.25","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1080\/14767058.2018.1550480","article-title":"Metformin-treated-GDM has lower risk of macrosomia compared to diet-treated GDM- a retrospective cohort study","volume":"33","author":"Bashir","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2025073111394159000_10.6.e003056.26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/jcm7030050","article-title":"Outcomes for women with gestational diabetes treated with metformin: a retrospective, case-control study","volume":"7","author":"McGrath","year":"2018","journal-title":"J Clin Med"},{"key":"2025073111394159000_10.6.e003056.27","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-0327"},{"key":"2025073111394159000_10.6.e003056.28","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S2213-8587(15)00219-3","article-title":"Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial","volume":"3","author":"Chiswick","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025073111394159000_10.6.e003056.29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/jog.13477","article-title":"Metformin as a prophylactic treatment of gestational diabetes in pregnant patients with pregestational insulin resistance: a randomized study","volume":"44","author":"Vald\u00e9s","year":"2018","journal-title":"J Obstet Gynaecol Res"},{"key":"2025073111394159000_10.6.e003056.30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S2213-8587(19)30002-6","article-title":"Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial","volume":"7","author":"L\u00f8vvik","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025073111394159000_10.6.e003056.31","doi-asserted-by":"crossref","first-page":"101376","DOI":"10.1016\/j.diabet.2022.101376","article-title":"Is there a residual risk of large-for-gestational-age infant related to gestational diabetes mellitus when it is treated?","volume":"48","author":"Cosson","year":"2022","journal-title":"Diabetes Metab"},{"key":"2025073111394159000_10.6.e003056.32","doi-asserted-by":"crossref","first-page":"101320","DOI":"10.1016\/j.diabet.2022.101320","article-title":"Residual risk associations between initial hyperglycemia and adverse pregnancy outcomes in a large cohort including 6709 women with gestational diabetes","volume":"48","author":"Li","year":"2022","journal-title":"Diabetes Metab"},{"key":"2025073111394159000_10.6.e003056.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2010.11.002"},{"key":"2025073111394159000_10.6.e003056.34","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3844-9"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2022-003056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T18:40:06Z","timestamp":1753987206000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2022-003056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,12,2]]},"published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1136\/bmjdrc-2022-003056"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2022-003056","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}